Given the protective associations observed with RBM6 and VEPH1 expression, vitamin D may enhance their beneficial effects, offering a synergistic approach to improve patient outcomes amidst the challenges posed by COVID-19. The gene discussed is VEPH1; the disease is COVID-19.